Akebia Therapeutics, Inc. (AKBA)
Total Valuation
AKBA has a market cap or net worth of $233.60 million. The enterprise value is $239.91 million.
| Market Cap | 233.60M |
| Enterprise Value | 239.91M |
Important Dates
The last earnings date was Wednesday, November 8, 2023, before market open.
| Earnings Date | Nov 8, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
AKBA has 188.39 million shares outstanding. The number of shares has increased by 2.41% in one year.
| Shares Outstanding | 188.39M |
| Shares Change (YoY) | +2.41% |
| Shares Change (QoQ) | +0.80% |
| Owned by Insiders (%) | 1.61% |
| Owned by Institutions (%) | 27.13% |
| Float | 167.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.21 |
| Forward PS | 1.20 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.38
| Current Ratio | 1.38 |
| Quick Ratio | 0.87 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.78 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -21.80% |
| Return on Capital (ROIC) | -409.78% |
| Revenue Per Employee | $949,074 |
| Profits Per Employee | -$299,480 |
| Employee Count | 204 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 1.79 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +145.16% in the last 52 weeks. The beta is 0.92, so AKBA's price volatility has been similar to the market average.
| Beta (1Y) | 0.92 |
| 52-Week Price Change | +145.16% |
| 50-Day Moving Average | 1.03 |
| 200-Day Moving Average | 1.06 |
| Relative Strength Index (RSI) | 64.50 |
| Average Volume (30 Days) | 1,380,277 |
Short Selling Information
The latest short interest is 7.33 million, so 3.89% of the outstanding shares have been sold short.
| Short Interest | 7.33M |
| Short Previous Month | 9.01M |
| Short % of Shares Out | 3.89% |
| Short % of Float | 4.38% |
| Short Ratio (days to cover) | 7.50 |
Income Statement
In the last 12 months, AKBA had revenue of $193.61 million and -$61.09 million in losses. Loss per share was -$0.33.
| Revenue | 193.61M |
| Gross Profit | 141.16M |
| Operating Income | -54.98M |
| Pretax Income | -61.09M |
| Net Income | -61.09M |
| EBITDA | -19.02M |
| EBIT | -54.85M |
| Loss Per Share | -$0.33 |
Balance Sheet
The company has $46.53 million in cash and $52.84 million in debt, giving a net cash position of -$6.31 million or -$0.03 per share.
| Cash & Cash Equivalents | 46.53M |
| Total Debt | 52.84M |
| Net Cash | -6.31M |
| Net Cash Per Share | -$0.03 |
| Equity / Book Value | -39.42M |
| Book Value Per Share | -0.21 |
| Working Capital | 29.90M |
Cash Flow
| Operating Cash Flow | -75.76M |
| Capital Expenditures | n/a |
| Free Cash Flow | -75.76M |
| FCF Per Share | -$0.40 |
Margins
Gross margin is 72.91%, with operating and profit margins of -28.40% and -31.56%.
| Gross Margin | 72.91% |
| Operating Margin | -28.40% |
| Pretax Margin | -31.56% |
| Profit Margin | -31.56% |
| EBITDA Margin | -9.83% |
| EBIT Margin | -28.33% |
| FCF Margin | -39.13% |
Dividends & Yields
AKBA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -26.15% |
| FCF Yield | -32.43% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.41% |
| Shareholder Yield | -2.41% |
Analyst Forecast
The average price target for AKBA is $4.33, which is 249.19% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.33 |
| Price Target Difference | 249.19% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 7.12% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AKBA has an Altman Z-Score of -8.87 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.87 |
| Piotroski F-Score | 3 |